Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Geretschläger, Andreas ^a   Bojaxhiu, Beat ^a   Crowe, Susanne ^b   Arnold, Andreas ^a   Manser, Peter ^a   Hallermann, Wock ^a   Aebersold, Daniel M ^a   Ghadjar, Pirus ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Head and neck cancer; IMRT; Oral cavity; Outcome; Postoperative

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER CONTROL; DISTANT METASTASIS FREE SURVIVAL; DYSPHAGIA; FEMALE; GLOSSECTOMY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE RESECTION; MAXILLA RESECTION; MOUTH SQUAMOUS CELL CARCINOMA; MUCOSA INFLAMMATION; NECK DISSECTION; NECK METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PLEURA METASTASIS; POSTOPERATIVE CARE; RADIATION DERMATITIS; RADIATION DOSE; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SKIN METASTASIS; SOFT TISSUE METASTASIS; TREATMENT FAILURE; TREATMENT PLANNING; XEROSTOMIA;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872682227     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-175     Document Type: Article

References (19)

1. Kramer S, Gelber RD, Snow JB, Marcial VA, Lowry LD, Davis LW, Chandler R. Combined radiation therapy and surgery in the management of head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987, 10:19-30. 10.1002/hed.2890100105, 3449477.
2. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 2008, 112:535-543. 10.1002/cncr.23206, 18076014.
3. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005, 27:843-850. 10.1002/hed.20279, 16161069.
4. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E. PARSPORT trial management group: Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicenter randomized controlled trial. Lancet Oncol 2011, 12:127-136. 10.1016/S1470-2045(10)70290-4, 3033533, 21236730.
5. Buettner F, Miah AB, Gulliford SL, Hall E, Harrington KJ, Webb S, Partridge M, Nutting CM. Novel approaches to improve the therapeutic index of head and neck radiotherapy: An analysis of data from the PARSPORT randomised phase III trial. Radiother Oncol 2012, 103:82-87. 10.1016/j.radonc.2012.02.006, 22444242.
6. van der Laan HP, Christianen ME, Bijl HP, Schilstra C, Langendijk JA. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: An in silico planning comparative study. Radiother Oncol 2012, 103:76-81. 10.1016/j.radonc.2011.11.001, 22112778.
7. Studer G, Zwahlen RA, Graetz KW, Davis BJ, Glanzmann C. IMRT in oral cavity cancer. Radiat Oncol 2007, 2:16. 10.1186/1748-717X-2-16, 1855346, 17430599.
8. Yao M, Chang K, Funk GF, Lu H, Tan H, Wacha J, Dornfeld KJ, Buatti JM. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy: The University of Iowa experience. Int J Radiat Oncol Biol Phys 2007, 67:1332-1341. 10.1016/j.ijrobp.2006.11.030, 17276613.
9. Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, Wolden SL, Pfister DG, Shaha A, Shah JP, Kraus DH, Wong RJ, Lee NY. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2009, 73:1096-1103. 10.1016/j.ijrobp.2008.05.024, 18707827.
10. Chen WC, Hwang TZ, Wang WH, Lu CH, Chen CC, Chen CM, Weng HH, Lai CH, Chen MF. Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol 2009, 45:505-510. 10.1016/j.oraloncology.2008.07.002, 18805047.
11. Daly ME, Lee QT, Kozak MM, Maxim PG, Murphy JD, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Chang DT. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control. Int J Radiat Oncol Biol Phys 2011, 80:1412-1422. 10.1016/j.ijrobp.2010.04.031, 20675073.
12. Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol 2010, 33:599-603. 10.1097/COC.0b013e3181c4c3cc, 21063195.
13. Sher DJ, Thotakura V, Balboni TA, Norris CM, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2011, 81:e215-e222. 10.1016/j.ijrobp.2011.02.023, 21531515.
14. AJCC cancer staging manual 2002, Philadelphia: Springer, Greene FL, Page DL, Fleming ID, 6.
15. Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006, 79:15-20. 10.1016/j.radonc.2006.03.009, 16616387.
16. Eisbruch A, Foote RL, O'Sullivan B, Beitler JJ, Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Rad Oncol 2002, 12:238-249.
17. Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, Eisbruch A. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000, 46:1117-1126. 10.1016/S0360-3016(99)00550-7, 10725621.
18. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003, 55:312-321. 10.1016/S0360-3016(02)03940-8, 12527043.
19. Tan HK, Giger R, Auperin A, Bourhis J, Janot F, Temam S. Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas - stratification for postsalvage survival. Head Neck 2010, 32:139-147.